rs41276738

Variant summary

Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PP4_ModeratePP1PM3_StrongPS3

This summary comes from the ClinGen Evidence Repository: The NM_000552.5(VWF):c.2561G>A variant in VWF is a missense variant predicted to cause substitution of arginine by glutamine at amino acid 854. The Grpmax filtering allele frequency in gnomAD v4.0 is 0.005857 (based on 7050/1180026 alleles, with 24 homozygotes) in the European non-Finnish population. This allele frequency is above the ClinGen VWD VCEP threshold for VWD Type 2N (<0.005) for PM2_Supporting but below the threshold (>0.01) for BS1 and therefore does not meet any population criterion. At least 9 patients with this variant displayed excessive mucocutaneous bleeding, low FVIII activity, and decreased VWF:FVIII binding, which is highly specific for VWD type 2N (PP4_Moderate, PMID:28971901, PMID:22875612). Four individuals were homozygous for the variant (PMID:28971901, PMID:22875612, PMID:1832934) and one of those individuals was compound heterozygous for the variant and a pathogenic variant (p.Arg816Trp) confirmed in trans (PMID:1832934), additional compound heterozygotes have been reported but were not considered here (PM3_Strong). In one family, the variant segregated with VWD type 2N in the proband and a second affected family member (PP1; PMID:28971901). A hydrodynamic mouse model showed reduced factor VIII stability and impaired binding of factor VIII to VWF, indicating that this variant has a damaging effect on protein function (PMID:28581694)(PS3). In summary, this variant meets the criteria to be classified as Pathogenic for von Willebrand disease type 2N. ACMG/AMP criteria applied as specified by the ClinGen von Willebrand disease Variant Curation Expert Panel: PS3, PM3_Strong, PP4_Moderate, PP1. LINK:https://erepo.genome.network/evrepo/ui/classification/CA114139/MONDO:0015631/090

Frequency

Genomes: 𝑓 0.0037 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0051 ( 23 hom. )

Consequence

VWF
NM_000552.5 missense

Scores

5
6
7

Clinical Significance

Pathogenic reviewed by expert panel P:49U:1O:2

Conservation

PhyloP100: 7.13

Publications

85 publications found
Variant links:
Genes affected
VWF (HGNC:12726): (von Willebrand factor) This gene encodes a glycoprotein involved in hemostasis. The encoded preproprotein is proteolytically processed following assembly into large multimeric complexes. These complexes function in the adhesion of platelets to sites of vascular injury and the transport of various proteins in the blood. Mutations in this gene result in von Willebrand disease, an inherited bleeding disorder. An unprocessed pseudogene has been found on chromosome 22. [provided by RefSeq, Oct 2015]
VWF Gene-Disease associations (from GenCC):
  • hereditary von Willebrand disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • von Willebrand disease 2
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
  • von Willebrand disease type 2B
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • von Willebrand disease 1
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • von Willebrand disease type 2A
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • von Willebrand disease type 2M
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • von Willebrand disease 3
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • von Willebrand disease type 2N
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 11 ACMG points.

PS3
For more information check the summary or visit ClinGen Evidence Repository.
PM3
For more information check the summary or visit ClinGen Evidence Repository.
PP1
For more information check the summary or visit ClinGen Evidence Repository.
PP4
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000552.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VWF
NM_000552.5
MANE Select
c.2561G>Ap.Arg854Gln
missense
Exon 20 of 52NP_000543.3P04275-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VWF
ENST00000261405.10
TSL:1 MANE Select
c.2561G>Ap.Arg854Gln
missense
Exon 20 of 52ENSP00000261405.5P04275-1
VWF
ENST00000895679.1
c.2561G>Ap.Arg854Gln
missense
Exon 21 of 53ENSP00000565738.1
VWF
ENST00000895680.1
c.2561G>Ap.Arg854Gln
missense
Exon 20 of 27ENSP00000565739.1

Frequencies

GnomAD3 genomes
AF:
0.00373
AC:
568
AN:
152236
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000916
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00314
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00556
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00605
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00340
AC:
856
AN:
251418
AF XY:
0.00353
show subpopulations
Gnomad AFR exome
AF:
0.000554
Gnomad AMR exome
AF:
0.00202
Gnomad ASJ exome
AF:
0.000893
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00564
Gnomad NFE exome
AF:
0.00536
Gnomad OTH exome
AF:
0.00342
GnomAD4 exome
AF:
0.00508
AC:
7432
AN:
1461860
Hom.:
23
Cov.:
31
AF XY:
0.00505
AC XY:
3672
AN XY:
727228
show subpopulations
African (AFR)
AF:
0.00108
AC:
36
AN:
33478
American (AMR)
AF:
0.00233
AC:
104
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00126
AC:
33
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000661
AC:
57
AN:
86254
European-Finnish (FIN)
AF:
0.00543
AC:
290
AN:
53420
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5768
European-Non Finnish (NFE)
AF:
0.00597
AC:
6638
AN:
1111988
Other (OTH)
AF:
0.00445
AC:
269
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
420
840
1260
1680
2100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
250
500
750
1000
1250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00373
AC:
568
AN:
152354
Hom.:
3
Cov.:
33
AF XY:
0.00357
AC XY:
266
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.000914
AC:
38
AN:
41592
American (AMR)
AF:
0.00314
AC:
48
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00556
AC:
59
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00606
AC:
412
AN:
68038
Other (OTH)
AF:
0.00189
AC:
4
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
30
60
91
121
151
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00492
Hom.:
8
Bravo
AF:
0.00351
TwinsUK
AF:
0.00512
AC:
19
ALSPAC
AF:
0.00675
AC:
26
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00558
AC:
48
ExAC
AF:
0.00308
AC:
374
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00474
EpiControl
AF:
0.00569

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
18
-
-
not provided (19)
10
1
-
von Willebrand disease type 2 (11)
7
-
-
von Willebrand disease type 1 (7)
4
-
-
von Willebrand disease type 2N (4)
3
-
-
Hereditary von Willebrand disease (4)
2
-
-
von Willebrand disease type 1;C1264040:von Willebrand disease type 2;C1264041:von Willebrand disease type 3 (2)
1
-
-
Abnormality of coagulation (1)
1
-
-
Thrombocytopenia;C1458140:Abnormal bleeding (1)
1
-
-
von Willebrand disease type 3 (1)
1
-
-
von Willebrand disorder (1)
1
-
-
VWF-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.024
T
BayesDel_noAF
Pathogenic
0.20
CADD
Pathogenic
30
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.75
D
Eigen
Pathogenic
0.76
Eigen_PC
Pathogenic
0.76
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.78
T
M_CAP
Uncertain
0.097
D
MetaRNN
Benign
0.043
T
MetaSVM
Benign
-0.40
T
MutationAssessor
Uncertain
2.1
M
PhyloP100
7.1
PrimateAI
Benign
0.47
T
PROVEAN
Uncertain
-3.6
D
REVEL
Uncertain
0.49
Sift
Benign
0.062
T
Sift4G
Pathogenic
0.0010
D
Polyphen
1.0
D
Vest4
0.91
MVP
0.88
MPC
0.72
ClinPred
0.032
T
GERP RS
5.6
Varity_R
0.51
gMVP
0.63
Mutation Taster
=56/44
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41276738; hg19: chr12-6143978; COSMIC: COSV99075179; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.